Cell-Free DNA MSI Detection Using Site-Specific Locus Thresholds

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for detecting microsatellite instability (MSI) in cell-free DNA (cfDNA) samples are underdeveloped, and the impact of variable tumor shedding on MSI detection has not been adequately addressed.

Innovation Solution

A method involving quantifying repeat lengths at microsatellite loci, generating site scores, comparing against trained thresholds, and classifying MSI status using probabilistic log likelihood-based scores to determine MSI status, which includes identifying customized therapies based on MSI results.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If PCR-based MSI assessment methods are used, then measurement precision is improved, but device complexity and ease of operation worsen due to requiring complex laboratory procedures

Engineering Contradiction:
ImproveMSI detection accuracyVSAvoidlaboratory procedure complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent replaces complex mechanical laboratory procedures (PCR-based assessment requiring specialized equipment and facilities) with computational methods that analyze existing sequencing data through probabilistic algorithms and bioinformatic pipelines, thereby maintaining measurement precision while eliminating device complexity

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent introduces computational algorithms and bioinformatic analysis pipelines as intermediaries between raw sequencing data and MSI status determination, serving as a bridge that translates complex biological data into clinically actionable results without requiring direct complex laboratory procedures at the point of care

Inventive Principle:
Principle #24Intermediary (Mediator)

2Ease of operation

If computational methods are used for MSI detection, then ease of operation is improved, but measurement precision worsens due to lack of validation

Engineering Contradiction:
ImproveMSI detection simplicityVSAvoidMSI detection accuracy
Core Design Contradiction:
Ease of operationVSMeasurement precision

Solution Approach 1:

The patent implements feedback mechanisms through iterative optimization of computational algorithms, where analysis results are continuously refined by comparing against known standards and adjusting parameters to maximize concordance with PCR-based methods, thereby ensuring measurement precision while maintaining ease of operation

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The patent performs preliminary validation and optimization of computational algorithms using training datasets before clinical application, establishing performance benchmarks and refining methods in advance to ensure measurement precision is achieved before the methods are deployed for routine MSI detection

Inventive Principle:
Principle #10Preliminary action

3Loss of information

If comprehensive genomic profiling is performed, then information completeness is improved, but loss of time worsens due to extended analysis requirements

Engineering Contradiction:
Improvegenomic information completenessVSAvoidanalysis time
Core Design Contradiction:
Loss of informationVSLoss of time

Solution Approach 1:

The patent extracts and prioritizes specific microsatellite loci and genomic regions that are most critical for MSI detection from comprehensive genomic data, separating essential information from supplementary data to deliver timely MSI results while maintaining information completeness for comprehensive profiling

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent segments the comprehensive genomic analysis into distinct analytical components, allowing parallel processing of different genomic regions and simultaneous execution of multiple analytical tasks, thereby reducing overall analysis time while preserving complete genomic information assessment

Inventive Principle:
Principle #1Segmentation

Data Source

PatentUS20260055472A1Microsatellite instability detection in cell-free DNA
Publication Date: 2026.02.26 GUARDANT HEALTH INC
  • US20260055472A1 patent drawing
  • US20260055472A1 patent drawing
  • US20260055472A1 patent drawing

AI summary

Provided herein are methods for determining the microsatellite instability status of samples. In one aspect, the methods include quantifying a number of different repeat lengths present at each of a plurality of microsatellite loci from sequence information to generate a site score for each of the plurality of the microsatellite loci. The methods also include comparing the site score of a given microsatellite locus to a site specific trained threshold for the given microsatellite locus for each of the plurality of the microsatellite loci and calling the given microsatellite locus as being unstable when the site score of the given microsatellite locus exceeds the site specific trained threshold for the given microsatellite locus to generate a microsatellite instability score, which includes a number of unstable microsatellite loci from the plurality of the microsatellite loci.